These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12147648)

  • 1. Tissue microarrays for predictive molecular pathology.
    Sauter G; Mirlacher M
    J Clin Pathol; 2002 Aug; 55(8):575-6. PubMed ID: 12147648
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue microarrays in clinical oncology.
    Voduc D; Kenney C; Nielsen TO
    Semin Radiat Oncol; 2008 Apr; 18(2):89-97. PubMed ID: 18314063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative in situ hybridization of tissue microarrays.
    Jubb AM; Pham TQ; Frantz GD; Peale FV; Hillan KJ
    Methods Mol Biol; 2006; 326():255-64. PubMed ID: 16780208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, construction, and use of tissue microarrays.
    Hewitt SM
    Methods Mol Biol; 2004; 264():61-72. PubMed ID: 15020780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue microarrays.
    Simon R; Mirlacher M; Sauter G
    Methods Mol Med; 2004; 97():377-89. PubMed ID: 15064506
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.
    Bubendorf L; Nocito A; Moch H; Sauter G
    J Pathol; 2001 Sep; 195(1):72-9. PubMed ID: 11568893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CINSARC signature: prognostic and predictive of response to chemotherapy?
    Bertucci F; Finetti P; Sabatier R; Birnbaum D
    Cell Cycle; 2010 Oct; 9(19):4025-7. PubMed ID: 20978372
    [No Abstract]   [Full Text] [Related]  

  • 8. From correlation to causality: microarrays, cancer, and cancer treatment.
    O'Neill GM; Catchpoole DR; Golemis EA
    Biotechniques; 2003 Mar; Suppl():64-71. PubMed ID: 12664688
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue microarrays: potential in the Indian subcontinent.
    Venkataraman G; Ananthanaranayanan V
    Indian J Cancer; 2005; 42(1):9-14. PubMed ID: 15805686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accurate confidence aware clustering of array CGH tumor profiles.
    van Houte BP; Heringa J
    Bioinformatics; 2010 Jan; 26(1):6-14. PubMed ID: 19846437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA microarrays and data analysis: an overview.
    Eschrich S; Yeatman TJ
    Surgery; 2004 Sep; 136(3):500-3. PubMed ID: 15349092
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiplex SNP discrimination.
    Fish DJ; Horne MT; Searles RP; Brewood GP; Benight AS
    Biophys J; 2007 May; 92(10):L89-91. PubMed ID: 17369420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic microarrays in cancer molecular diagnostics: just biomarker discovery tools or future bedside clinical assays?
    Ross JS
    Expert Rev Mol Diagn; 2005 Nov; 5(6):837-8. PubMed ID: 16255622
    [No Abstract]   [Full Text] [Related]  

  • 14. Conjugated polyelectrolytes for label-free DNA microarrays.
    He F; Feng F; Wang S
    Trends Biotechnol; 2008 Feb; 26(2):57-9. PubMed ID: 18191257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing microarray data: What technology is needed?
    Hollon T
    J Natl Cancer Inst; 2001 Aug; 93(15):1126-7. PubMed ID: 11481378
    [No Abstract]   [Full Text] [Related]  

  • 16. DualChip microarray as a new tool in cancer research.
    Gillet JP; de Longueville F; Remacle J
    Expert Rev Mol Diagn; 2006 May; 6(3):295-306. PubMed ID: 16706734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies.
    NicoĊ› M; Wojas-Krawczyk K; Krawczyk P; Milanowski J
    Adv Clin Exp Med; 2015; 24(4):715-23. PubMed ID: 26469118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of microarray profiling to clinical trials in cancer.
    Olson JA
    Surgery; 2004 Sep; 136(3):519-23. PubMed ID: 15349095
    [No Abstract]   [Full Text] [Related]  

  • 19. Long non-coding RNA chromogenic in situ hybridisation signal pattern correlation with breast tumour pathology.
    Zhang Z; Weaver DL; Olsen D; deKay J; Peng Z; Ashikaga T; Evans MF
    J Clin Pathol; 2016 Jan; 69(1):76-81. PubMed ID: 26323944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tissue microarrays a powerful tool in transfer and quality control in oncology].
    Jacquemier J; Ginestier C; Bertucci F; Jauffret EC; Geneix J; Birnbaum D
    Bull Cancer; 2003 Jan; 90(1):31-8. PubMed ID: 12609802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.